Trust Investment Advisors Gilead Sciences, Inc. Transaction History

Trust Investment Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 28, 2023	BUY	$62.32 - $89.47 $174,620 - $250,694	2,802 New	2,802 $240,000
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $709,114 - $888,596	-12,243 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $9,926 - $11,266	153 Added 1.27%	12,243 $889,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $9,070 - $9,786	134 Added 1.12%	12,090 $844,000
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $29,957 - $32,733	472 Added 4.11%	11,956 $823,000
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $689,040 - $786,194	11,484 New	11,484 $742,000
Q1 2018 May 29, 2018	SELL	$72.84 - $88.8 $304,471 - $371,184	-4,180 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $85,380 - $100,224	-1,200 Reduced 22.3%	4,180 $299,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $387,951 - $459,828	5,380	5,380 $436,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Trust Investment Advisors with notifications on news.